Radical Catheter Technologies’ 8F Neurovascular Catheter Receives US FDA 510(k) Clearance, Second for the Best-in-Class Ribbon Technology Platform
15 janv. 2025 09h00 HE
|
Radical Catheter Technologies
CAMPBELL, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Radical™ Catheter Technologies, a pioneering medical device company focused on advancing the next generation of endovascular access and delivery,...
E8, Inc. Announces Collaborative Partnership with Jacobs Institute to Make Minimally Invasive Solutions the Gold Standard in Neurosurgery
14 janv. 2025 08h00 HE
|
E8, Inc.
LOS GATOS, Calif., Jan. 14, 2025 (GLOBE NEWSWIRE) -- E8, Inc. unveiled its next-generation suite of tools designed to turn the promise of minimally invasive neurosurgical access devices, including...
R3 Vascular Secures WCG IRB Approval and CMS Category B Medicare Coverage for the ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
13 janv. 2025 06h00 HE
|
R3 Vascular
MOUNTAIN VIEW, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating...
PortIO Completes Keiretsu Forum MST Due Diligence, Paving the Way for Fast-Track Funding
08 janv. 2025 07h25 HE
|
Keiretsu Forum Mid-Atlantic
PortIO Corp’s decision to engage K4-MST underscores Keiretsu’s proven track record of advancing life sciences and medical technology ventures.
electroCore Expands Intellectual Property Portfolio
07 janv. 2025 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., Jan. 07, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it has received five patent...
Vivos Inc. Announces Launch of Groundbreaking RadioGel® Precision Radionuclide Therapy™ Human Clinical Trial
23 déc. 2024 08h30 HE
|
Vivos Inc.
Richland, WA, Dec. 23, 2024 (GLOBE NEWSWIRE) -- – Vivos Inc. (OTCQB: RDGL) proudly announces the initiation of its first human clinical trial for RadioGel® Precision Radionuclide Therapy™ in India....
Signati™ Medical Successfully Completes IDE Trial for Separo™ Vessel Sealing System and Initiates FDA Market Clearance Process
23 déc. 2024 08h00 HE
|
Signati Medical Inc.
Providence, RI, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Signati™ Medical is proud to announce the successful completion of its Investigational Device Exemption (IDE) trial evaluating the Separo™ Vessel...
Infusion Pump Market is expected to generate a revenue of USD 24.09 Billion by 2031, Globally, at 6% CAGR: Verified Market Research®
19 déc. 2024 10h00 HE
|
Verified Market Research
Jersey City, New Jersey, Dec. 19, 2024 (GLOBE NEWSWIRE) -- The Global Infusion Pump Market Size is projected to grow at a CAGR of 6.0% from 2024 to 2031, according to a new report published by...
Global Medical Devices Market to Surge to $1.3 Trillion, Driven by Advances in AI
18 déc. 2024 07h15 HE
|
BCC Research LLC
Boston, Dec. 18, 2024 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research the "Global Market for Medical Device Technologies” is expected to grow from $810.4 billion in 2024 to $1.3...
Medical Device Engineering Markt Share is expected to generate a revenue of 23.35 billion by 2034 to register a CAGR of 10.0% | PMR
18 déc. 2024 06h04 HE
|
Polaris Market Research & Consulting LLP
New York, USA, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Market Facts The global medical device engineering market size was USD 9.05 billion in 2024, estimated at USD 9.93 billion in 2025, and is expected...